Cited by 197Dementia and Cognitive Impairment ResearchCOVID-19 and Mental HealthLong-Term Effects of COVID-19

Neuropsychiatric symptoms and quality of life in Spanish patients with Alzheimer’s disease during the COVID‐19 lockdown

Open access
Lara, B., Carnes, A., Dakterzada, F., Benitez, I., Piñol‐Ripoll, G.·2020·European Journal of Neurology

Abstract

BACKGROUND AND PURPOSE: The COVID-19 epidemic is affecting almost all individuals worldwide, and patients with Alzheimer's disease (AD) and amnesic mild cognitive impairment (MCI) are particularly at risk due to their characteristics and age. We analysed the impact of the pandemic on these patients' neuropsychiatric symptoms and their quality of life after 5 weeks of lockdown in Spain. METHODS: A total of 40 patients with a diagnosis of MCI (n = 20) or mild AD (n = 20) from the Cognitive Stimulation Program of the Cognitive Disorders Unit were evaluated. All patients had undergone a previous evaluation during the month before the lockdown, and were re-evaluated after 5 weeks of lockdown. The Neuropsychiatric Inventory (NPI) and EuroQol-5D questionnaire (EQ-5D) were used to assess neuropsychiatric symptoms in patients and the quality of life in patients as well in caregivers. RESULTS: The mean (SD) total baseline NPI score was 33.75 (22.28), compared with 39.05 (27.96) after confinement (P = 0.028). The most frequently affected neuropsychiatric symptoms were apathy [4.15 (3.78) vs. 5.75 (4.02); P = 0.002] and anxiety [3.95 (3.73) vs. 5.30 (4.01); P = 0.006] in patients with MCI, and apathy [2.35 (2.70) vs. 3.75 (3.78); P = 0.036], agitation [0.45 (1.14) vs. 1.50 (2.66); P = 0.029] and aberrant motor behaviour [1.25 (2.86) vs. 2.00 (2.93); P = 0.044] in patients with AD. We did not observe differences in EQ-5D scores during the re-evaluation. The 30% of patients and 40% of caregivers reported a worsening of the patients' health status during confinement. CONCLUSIONS: The results of this study show the worsening of neuropsychiatric symptoms in patients with AD and MCI during 5 weeks of lockdown, with agitation, apathy and aberrant motor activity being the most affected symptoms.

Integrity signals

Registry

Crossref · 10.1111/ene.14339

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lara, B., Carnes, A., Dakterzada, F., Benitez, I., & Piñol‐Ripoll, G.
Affiliations
  • Hospital Universitari de Santa Maria (ES)
  • Hospital Universitari Arnau de Vilanova (ES)
Corresponding author
Piñol‐Ripoll, G.
Venue
European Journal of Neurology
Publisher
Wiley
Published
2020-06-24
Volume
27
Issue
9
Pages
1744-1747
ISSN
  • 1351-5101 (ISSN-L)
  • 1468-1331
OpenAlex
W3026319603
Cited by
197
References
12
Citations by year
2025: 10 · 2024: 18 · 2023: 19 · 2022: 68 · 2021: 60 · 2020: 21 · 2012: 1
FWCI
30.64
Type
journal article
Language
en
Open access
Locations
  • European Journal of Neurology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Repositori ObertUDL (University of Lleida) (acceptedVersion)
Funders
Agència de Gestió d'Ajuts Universitaris i de Recerca (FI_B100153, SLT008/18)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
Keywords
Alzheimer's disease, amnestic mild cognitive impairment, neuropsychiatric symptoms, COVID-19 lockdown, quality of life, apathy, anxiety, agitation, caregiver burden, cognitive stimulation, Spain, EuroQol-5D, Neuropsychiatric Inventory, caregiver anxiety
MeSH terms
COVID-19, Aged, Aged, 80 and over, Alzheimer Disease, Anxiety, Female, Humans, Male, Neuropsychological Tests, Psychomotor Agitation, Quality of Life, Quarantine, Surveys and Questionnaires, Spain, Apathy, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review